Apart from the questions which involve a medical problem with one of your glands, this section has also ended up with all the questions about nutrition and malnutrition, including cachexia and morbid obesity.
Question 14 | Nutrition in the ICU: a generic approach |
Question 17 | Adrenal insufficiency: causes, biochemistry and management |
Question 9 |
Question 5.2 |
Question 14 |
Question 10.1 |
Question 23 | Assessment of malnutrition and pathophysiology of refeeding syndrome |
Question 9 |
Question 28 | Phaeochromocytoma: clinical features, investigations and management |
Question 25 | |
Question 9.1 | Raised serum/urine catecholamine levels: what could they mean? |
Question 13 |
Question 12.2 | ECG changes and acid-base disturbance in myxoedema coma |
Question 8 | Consequences of morbid obesity in the critically ill patient |
Question 24 | |
Question 23 | Hypocaloric enteral nutrition: permissive underfeeding and "trophic" feeding |
Question 15.1 | Thyrotoxicosis following trans-sphenoidal pituitary surgery |
Question 30.1 | Hypoosmolar hyponatremia - postpartum hypopituitarism, Sheehan's syndrome |
Question 14 | Assessment of nutritional status; also, pathophysiology of refeeding syndrome |
Question 3.3 | Wernicke's encephalopathy, masquerading as a question about macrocytosis |
Question 1 |
Question 13 | Perioperative management of the morbidly obese patient (post sleeve gastrectomy) |
Question 7 | Estimation of energy expenditure in critical illness; also TPN prescription |
Question 25 | Nutrition for the patient with severe pancreatitis; also complications of enteral nutrition. |
Question 30.1 | Hypoosmolar hyponatremia due to amiodarone-induced myxoedema coma |
Question 17 | Diabetic ketoacidosis vs. HONK: distinguishing features and management of HONK. |
Question 7.4 |
Question 27 | Metabolic changes in starvation; and the metabolic adaptations of the stress response |
Question 25 | Sick euthyroid syndrome, effect of drugs on thyroid, and management of thyrotoxicosis |
Question 13.3 |
Question 26.1 | Refeeding syndrome- a characteristic electrolyte panel |
Question 24 | Nutrition for the morbidly obese ICU patient. Also, effects of obesity on metabolism. |
Question 11.1 | Carcinoid syndrome; specifically, clinical features, and diagnostic biochemistry. |
Question 12 | Enteral vs parenteral nutrition; specifically in the context of pancreatitis |
Question 2 | Cachexia: a definition, risk factors, and consequences. |
Question 17 |
Question 25.4 | |
Question 22 | Phaeochromocytoma. Investigations, management, complications. |
Question 20 |
Question 4 | Stress-induced hyperglycaemia: mechanisms, consequences and management. |
Question 19 | |
Question 2 |
Question 14.1 | Causes of raised plasma catecholamine levels: its not always phaeochromocytoma |
Question 18.1 | HONK: what are the possible complications? |
Question 20 | A comparison of enteral feeding tubes and routes of enteral nutrition |
Question 15.3 | Causes of hypoglycaemia in a Type 1 diabetic. |
Question 15.2 | Phaeochromocytoma, again. |
Question 15.1 | Myxoedema coma - due to amiodarone. Specifics of management. |
Question 9.2 |
Question 28 |
Question 28 |
Question 24 | Causes of hyperglycaemia in the ICU, and its management. |
Question 7 |
Question 23 | |
Question 19 |
Question 8 | Adrenal insufficiency: causes, consequences and management. |
Question 3 | Immunonutrition - "critically evaluate" |
Question 15 | A comparison of enteral feeding tubes and routes of enteral nutrition |
Question 11 |
Question 13 | |
Question 7 | Causes of hyperglycaemia in the ICU. Glycaemic control in critical illness. |
Question 9 | |
Question 5 | Contents and properties of TPN: role of lipid mixture in pancreatitis |
Question 10 |
Question 15 | Fluid resuscitation of diabetic ketoacidosis: Choice of crystalloid. |